CANTON, Mich. and OTTAWA (October 18, 2022) – TrialAssure, a leading, global software-as-a- service (SaaS) provider advancing clinical trial disclosure, data sharing, and transparency, announced today that it has surpassed 30,000,000 markups in its best-selling product TrialAssure ANONYMIZE(R). The announcement comes at the onset of the DIA Canada Annual Meeting this week in Ottawa, Ontario.

A markup is an individual piece of text that TrialAssure identifies, categorizes, and transforms to reduce and help eliminate the chance of re-identification of personal protected information (PPI) or protect commercial confidential information (CCI).

“We built this software to empower the pharmaceutical industry to share information with confidence, knowing that patient and company confidentiality are protected, and this milestone gives us reason to take notice and celebrate the achievements of our team during this transformational regulatory period,” said Zach Weingarden, Director of Product Solutions, TrialAssure.

This milestone is the culmination of hundreds of client projects and nearly 8,000,000 pages of documentation prepared for submission to pharmaceutical industry regulators across Canada, Europe, and the United States.

With ANONYMIZE, Sponsors can:

  • Shield structured and unstructured clinical documents, datasets, and medical images, as well as quantify the risk of re-identification and generate risk assessment reports
  • Facilitate further research by maintaining the integrity of study data and enabling secondary analysis
  • Meet new compliance requirements set by global health authorities

Weingarden added, “From the first submissions of anonymized and redacted information to Health Canada until now, TrialAssure has been at the forefront of providing strong, reliable, and efficient software to sponsors, and we will continue to live up to our missions to facilitate transparency for the entire pharmaceutical industry.”

Request to see a demo of how this proprietary software works at

About TrialAssure

TrialAssure is a leading, global clinical trial disclosure and data transparency provider with unmatched experience in helping navigate complex regulatory compliance challenges. TrialAssure provides fast, affordable, and intelligent software and service solutions to facilitate clinical trial disclosure (registration and results reporting), document and data anonymization, and enhanced patient engagement, while delivering the highest quality clinical trial transparency deliverables that exceed the most stringent requirements. Established in 2009, TrialAssure regularly adapts to ever-changing clinical trial disclosure and data transparency requirements and was named Data Solution of the Year – Healthcare in the Data Breakthrough Awards. For more information, visit or follow TrialAssure on LinkedIn.  

Media contact

Don F. McLean,